Progression to type 1 diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase (GAD65)

Clinical Immunology

Volumn 90, Issue 2, 1999, Pages 276-281

  Petersen, J S ^a   Kulmala, P ^b   Clausen, J T ^a   Knip, M ^b   Dyrberg, T ^a,b  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Autoantibodies; Autoimmunity; IDDM; Immunoglobulin isotypes; Prediction

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032906646     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4641     Document Type: Article

References (22)

1. Kaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., and Lehmann, P. V., Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366, 69-72, 1994.
2. Petersen, J. S., Karlsen, A. E., Markholst, H., Worsaae, A., Dyrberg, T., and Michelsen, B., Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 43, 1478-1484, 1994.
3. Petersen, J. S., Dyrberg, T., Karlsen, A. E., Mølvig, J., Nerup, J., Mandrup-Poulsen, T., and the Canadian-European Randomized Control Trial Group, Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent onset insulin-dependent diabetes mellitus following cyclosporin-treatment. Diabetes 43, 1291-1296, 1994.
4. Petersen, J. S., Dyrberg, T., Damm, P., Kühl, C., Mølsted-Pedersen, L., and Buschard, K., GAD65 autoantibodies in women with gestational or type 1 diabetes mellitus diagnosed during pregnancy. Diabetologia 39, 1329-1333, 1996.
5. Petersen, J., Hejnæs, K. R., Moody, A., Karlsen, A. E., Marshall, M. O., Høier-Madsen, M., Boel, E., Michelsen, B., and Dyrberg, T., Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43, 459-467, 1994.
6. Nicholson, L. B., and Kuchroo, V. K., Manipulation of the Th1/ Th2 balance in autoimmune diseases. Curr. Opin. Immun. 8, 837-842, 1996.
7. Liblau, R. S., Singer, S. M., and McDevitt, H. O., Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38, 1995.
8. Rapoport, M. J., Jaramillo, A., Zipris, D., Lazarus, A. H., Serreze, D. V., Leither, E. H., Cyopick, P., Danska, J. S., and Delovitch, T. L., Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178, 87-99, 1997.
9. Elias, D., and Cohen, I. R., The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin. Diabetes 45, 1168-1172, 1996.
10. Tian, J., Atkinson, M. A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmenn, P. V., and Kaufman, D. L., Nasal administration of glutamic decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183, 1561-1567, 1996.
11. Siebenkotten, G., and Radbruch, A., Towards a molecular understanding of immunoglobulin class switching. Immunologist 3, 141-145, 1995.
12. King, C. L., and Nutman, T. B., IgE and IgG4 subclass regulation by IL-4 and IFN-gamma in human helminth infections. Assessment by B cell precursor frequencies. J. Immunol. 151, 458-465, 1993.
13. Kulmala, P., Savola, K., Petersen, J., Vähäsalo, P., Karjalainen, J., Löppönen, T., Dyrberg, T., Åkerblom, H. K., Knip, M., and the Childhood Diabetes in Finland Study Group, Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes - A population based study. J. Clin. Invest. 101, 327-336, 1998.
14. Reimer, C. B., Phillips, D. J., Aloisio, C. H., Moore, D. D., Galland, G. G., Wells, T. W., Black, C. M., and McDougal, J., Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. Hybridoma 3, 263-275, 1984.
15. Bayer, E. A., and Wilchek, M., The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem. Anal. 26, 1-45, 1980.
16. Petersen, J. S., Kyvik, K. O., Bingley, P. J., Gale, E. A. M., Green, A., Dyrberg, T., and Beck-Niselsen, H., Population based study of prevalence of islet cell autoantibodies in monocygotic and dizygotic Danich twin pairs with insulin dependent diabetes mellitus. Br. Med. J. 31, 1575-1579, 1997.
17. Daw, K., Ujihara, N., Atkinson, M., and Powers, A. C., Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J. Immunol. 156, 818-825, 1996.
18. Verge, C. F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Jackson, R. A., Chase, H. P., and Eisenbarth, G. S., Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45, 926-933, 1996.
19. Zouali, M., Jefferis, R., and Eyquem, A., IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases. Immunology 51, 595-600, 1984.
20. Dozio, N., Sodoyez-Goffaux, F., Koch, M., Ziegler, B., and Sodoyez, J. C., Polymorphism of insulin antibodies in six patients with insulin-immune hypoglycemic syndrome. Clin. Exp. Immunol. 85, 282-287, 1991.
21. Guo, J., Rapoport, B., and McLanchlan, S. M., Thyroid peroxidase autoantibodies of IgE class in Thyroid autoimmunity. Clin. Immunol. Immunopathol. 82, 157-162, 1997.
22. Dozio, N., Belloni, C., Girardi, A. M., Genovese, S., Sodoyez, J. C., Bottazzo, G. F., Pozza, G., and Bosi, E., Heterogeneous IgG subclass distribution of islet cell antibodies. J. Autoimmun. 7, 45-53, 1994.